Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Triple Negative Breast Cancer Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07741968
What this trial is testing

A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+15 more
City of Hope Medical Center 126
Testing effectiveness (Phase 2)UnknownNCT02587689
What this trial is testing

Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor

Who this might be right for
Hepatocellular CarcinomaNon-small Cell Lung CancerPancreatic Carcinoma+1 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 20
Not applicableActive Not RecruitingNCT07421479
What this trial is testing

Patient-Derived Breast Cancer Organoids for Therapeutic Extracellular Vesicle Isolation (PDO-Mercurial01)

Who this might be right for
Invasive Breast Cancer
Istituti Clinici Scientifici Maugeri SpA 50
Testing effectiveness (Phase 2)UnknownNCT01939054
What this trial is testing

Nimotuzumab Plus Docetaxel and Capecitabine Versus Docetaxel and Capecitabine in the Treatment of Breast Cancer Patients

Who this might be right for
Breast Cancer
Chinese Academy of Medical Sciences 90
Testing effectiveness (Phase 2)Study completedNCT01097642
What this trial is testing

Neo-Adjuvant Study in Triple Negative Breast Cancer Patients

Who this might be right for
Breast Cancer
The Methodist Hospital Research Institute 40
Early research (Phase 1)Study completedNCT03096054
What this trial is testing

A Phase I Trial of LY3143921 Hydrate in Solid Tumours

Who this might be right for
Colorectal CancerHigh Grade Serous Ovarian CancerNon Small-cell Lung Cancer (Squamous Cell Variant)+4 more
Cancer Research UK 69
Early research (Phase 1)Study completedNCT02719691
What this trial is testing

Phase I Study of MLN0128 and MLN8237 in Patients With Advanced Solid Tumors and Metastatic Triple-negative Breast Cancer

Who this might be right for
Metastatic Breast CancerSolid Tumors
University of Colorado, Denver 47
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07007780
What this trial is testing

Sacituzumab Tirumotecan in Neoadjuvant Treatment of Early-Stage TNBC

Who this might be right for
Triple -Negative Breast Cancer
Xijing Hospital 35
Early research (Phase 1)Study completedNCT01674842
What this trial is testing

Cisplatin + RT for Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 55
Post-approval studies (Phase 4)UnknownNCT02089854
What this trial is testing

Adjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast Cancer

Who this might be right for
Female Breast Cancer
Peking Union Medical College Hospital 800
Not applicableLooking for participantsNCT06431100
What this trial is testing

A Single-arm, Single-center, Open Clinical Study

Who this might be right for
Gastric CancerEsophageal CancerCervical Cancer+2 more
Beijing Geekgene Technology Co., LTD 10
Testing effectiveness (Phase 2)Study completedNCT04699630
What this trial is testing

U3-1402 (Patritumab Deruxtecan) in Subjects With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast CancerLocally Advanced Breast Cancer
SCRI Development Innovations, LLC 121
Not applicableEnded earlyNCT06231693
What this trial is testing

Trastuzumab-deruxtecan in Patients With Triple-negative Metastatic HER2-Low Breast Cancer: Real-world Experience in Brazil

Who this might be right for
Breast Cancer
AstraZeneca 2
Large-scale testing (Phase 3)Study completedNCT00528567
What this trial is testing

BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 2,591
Not applicableNot Yet RecruitingNCT07527819
What this trial is testing

Evaluating Ovarian Toxicity Outcomes Following Immunotherapy in Patients With Triple-Negative Breast Cancer (TNBC)

Who this might be right for
Triple Negative Breast Cancer (TNBC)
Peter MacCallum Cancer Centre, Australia 75
Not applicableStudy completedNCT01498536
What this trial is testing

Effect of Diet and Exercise in Breast Cancer Survivors

Who this might be right for
Breast CancerObesity
West Virginia University 28
Early research (Phase 1)UnknownNCT02950064
What this trial is testing

Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations

Who this might be right for
Pancreatic NeoplasmsOvarian NeoplasmsBreast Neoplasms+1 more
Placon Therapeutics 95
Large-scale testing (Phase 3)Looking for participantsNCT07111832
What this trial is testing

A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer

Who this might be right for
PD-L1-positive Locally Recurrent Unresectable or Metastatic Triple-negative Breast Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 400
Testing effectiveness (Phase 2)Study completedNCT01931163
What this trial is testing

NECTAR Everolimus Plus Cisplatin in Triple (-) Breast Cancer

Who this might be right for
Breast CancerTriple Negative Breast Cancer
Jenny C. Chang, MD 24
Large-scale testing (Phase 3)Active Not RecruitingNCT02641847
What this trial is testing

TA(E)C-GP Versus A(E)C-T for the High Risk TNBC Patients and Validation of the mRNA-lncRNA Signature

Who this might be right for
Triple Negative Breast CancerBreast Cancer
Fudan University 503
Next Page